1.Sequential changes of traumatic vertebral compression fracture on MR imaging.
Mi S SUNG ; Seog H LEE ; Jae M LEE ; Hong J JUNG ; Jung I YIM ; Youn S KIM ; Kyung S SHINN
Journal of Korean Medical Science 1995;10(3):189-194
The purpose of this study was to evaluate the sequential signal intensity changes in post-traumatic vertebral compression fractures of varying ages. Sixty-six patients with 115 post-traumatic vertebral compression fractures underwent MR imaging. The ages of fractures at the time of MR images ranged from 1 day to 6 years. Sequential follow-up MR imagings were obtained in 4 patients for 2 years after initial MR examination. The fracture sites in all 52 fractures with traumatic events less than 3 months prior were hypointense on T1-weighted images and hyperintense on T2-weighted images (type I). A type I fracture could be subdivided into 3 patterns depending on its morphologic appearance: diffuse (type Ia); patchy (type Ib); and bandlike (type Ic). In 12 fractures of 3 to 5 months after trauma, six showed focal hypointensity (type II) in all pulse sequences, and six showed isointensity (type IV). Four of 51 fractures with trauma over 5 months showed focal hyperintensity on T1-weighted images and isointensity on T2-weighted images (type III); and the remaining 47 fractures showed isointensity on all sequences (type IV). In conclusion, MR imaging is useful in predicting the age of known traumatic compression fractures, so familiarity with these sequential MR findings would be helpful in distinguishing benign from malignant fractures.
Adult
;
Aged
;
Female
;
Human
;
Lumbar Vertebrae/*injuries
;
*Magnetic Resonance Imaging
;
Male
;
Middle Age
;
Spinal Fractures/*diagnosis
;
Time Factors
2.Ethnic Differences in Intracranial Artery Tortuosity: A Possible Reason for Different Locations of Cerebral Atherosclerosis
Bum Joon KIM ; Kyung Mi LEE ; Sung Ho LEE ; Hyug Gi KIM ; Eui Jong KIM ; Sung Hyuk HEO ; Dae il CHANG ; Jong S KIM
Journal of Stroke 2018;20(1):140-141
No abstract available.
Arteries
;
Intracranial Arteriosclerosis
3.Cognitive Dysfunctions in Positive and Negative Schizophrenic Patients with or without Tardive Dyskinesia.
Bum Hee YU ; Ji Hae KIM ; Joo Mi BAE ; Kang Uk LEE ; Jong Min WOO ; S Peter KIM
Journal of Korean Neuropsychiatric Association 1998;37(1):38-47
OBJECTIVE: The goal of this study was to examine cognitive dysfunctions in positive and negative schizophrenic patients and investigate the effect of tardive dyskinesia on cognitive dysfunctions in them. METHODS: Thirty two schizophrenic patients with tardive dyskinesia and thirty two schizophrenic patients without tardive dyskinesia as a control group were selected some psychiatric inpatients at a lunatic asylum and the cognitive dysfunctions of these patients were assessd with some neuropsychological tests including KWIS test, Grooved Pegboard test, Trail making test A and B, Wisconsin card sorting test, and Wechsler memory scale test. From these patients, we classified eighteen schizophrenic patients as a positive syndrome group and twenty five patients as a negative syndrome group with positive and negative syndrome scale and compared the results of neuropsychological tests between these two groups. RESULTS: Patients without tardivc dyskinesia showed better performances than those with tardive dyskinesia on picture completion subtest of KWIS. Positive schizophrenic patients showed better performances than negative schizophrenic patients on comprehension subtest of KWIS and trail making test A. CONCLUSION: Negative schizophrenic patients showed frontal lobe dyfunction and more memory impairment than positive schizophrenic patients. In conclusion, negative syndrome of schizophrenia is significantly associated with cognitive dysfunctions although tardive dyskinesia is not.
Comprehension
;
Dyskinesias
;
Frontal Lobe
;
Humans
;
Inpatients
;
Memory
;
Movement Disorders*
;
Neuropsychological Tests
;
Schizophrenia
;
Trail Making Test
;
Wisconsin
4.Wall Shear Stress Associated with Stroke Occurrence and Mechanisms in Middle Cerebral Artery Atherosclerosis
Ho Geol WOO ; Hyug-Gi KIM ; Kyung Mi LEE ; Sang Hee HA ; HangJin JO ; Sung Hyuk HEO ; Dae-il CHANG ; David S. LIEBESKIND ; Bum Joon KIM
Journal of Stroke 2023;25(1):132-140
Background:
and Purpose Various mechanisms are involved in the etiology of stroke caused by atherosclerosis of the middle cerebral artery (MCA). Here, we compared differences in plaque nature and hemodynamic parameters according to stroke mechanism in patients with MCA atherosclerosis.
Methods:
Consecutive patients with asymptomatic and symptomatic MCA atherosclerosis (≥50% stenosis) were enrolled. MCA plaque characteristics (location and plaque enhancement) and wall shear stress (WSS) were measured using high-resolution vessel wall and four-dimensional flow magnetic resonance imaging, respectively, at five points (initial, upstream, minimal lumen, downstream, and terminal). These parameters were compared between patients with asymptomatic and symptomatic MCA atherosclerosis with infarctions of different mechanisms (artery-to-artery embolism vs. local branch occlusion).
Results:
In total, 110 patients (46 asymptomatic, 32 artery-to-artery embolisms, and 32 local branch occlusions) were investigated. Plaques were evenly distributed in the MCA of patients with asymptomatic MCA atherosclerosis, more commonly observed in the distal MCA of patients with artery-to-artery embolism, and in the middle MCA of patients with local branch occlusion. Maximum WSS and plaque enhancement were more prominent in the minimum lumen area of patients with asymptomatic MCA atherosclerosis or those with local branch occlusion, and were more prominent in the upstream area in those with artery-to-artery embolism. The elevated variability in the maximum WSS was related to stroke caused by artery-to-artery embolism.
Conclusion
Stroke caused by artery-to-artery embolism was related to plaque enhancement and the highest maximum WSS at the upstream point of the plaque, and was associated with elevated variability of maximum WSS.
5.Explanatory Power and Prognostic Implications of Factors Associated with Troponin Elevation in Acute Ischemic Stroke
Sung-Ho AHN ; Ji-Sung LEE ; Mi-Sook YUN ; Jung-Hee HAN ; Soo-Young KIM ; Young-Hak KIM ; Sang-Hyun LEE ; Min-Gyu PARK ; Kyung-Pil PARK ; Dong-Wha KANG ; Jong S. KIM ; Sun U. KWON
Journal of Stroke 2023;25(1):141-150
Background:
and Purpose We investigated the impact of comorbidity burden on troponin elevation, with separate consideration of neurological conditions, in patients with acute ischemic stroke (AIS).
Methods:
This prospective, observational cohort study consecutively enrolled patients with AIS for 2 years. Serum cardiac troponin I was repeatedly measured, and disease-related biomarkers were collected for diagnosis of preassigned comorbidities, including atrial fibrillation (AF), ischemic heart disease (IHD), myocardial hypertrophy (MH), heart failure (HF), renal insufficiency (RI), and active cancer. The severity of neurological deficits and insular cortical ischemic lesions were assessed as neurological conditions. Adjusted associations between these factors and troponin elevation were determined using a multivariate ordinal logistic regression model and area under the receiver operating characteristic curve (AUC). Cox proportional hazards model was used to determine the prognostic significance of comorbidity beyond neurological conditions.
Results:
Among 1,092 patients (66.5±12.4 years, 63.3% male), 145 (13.3%) and 335 (30.7%) had elevated (≥0.040 ng/mL) and minimally-elevated (0.040–0.010 ng/mL) troponin, respectively. In the adjusted analysis, AF, MH, HF, RI, active cancer, and neurological deficits were associated with troponin elevation. The multivariate model with six comorbidities and two neurological conditions exhibited an AUC of 0.729 (95% confidence interval [CI], 0.698–0.759). In Cox regression, AF, IHD, and HF were associated with adverse cardio-cerebrovascular events, whereas HF and active cancer were associated with mortality.
Conclusion
Troponin elevation in patients with AIS can be explained by the burden of comorbidities in combination with neurological status, which explains the prognostic significance of troponin assay.
6.Detection of Bartonella species from ticks, mites and small mammals in Korea.
Chul Min KIM ; Ji Young KIM ; Ying Hua YI ; Mi Jin LEE ; Mae rim CHO ; Devendra H SHAH ; Terry A KLEIN ; Heung Chul KIM ; Jin Won SONG ; Sung Tae CHONG ; Monica L O'GUINN ; John S LEE ; In Yong LEE ; Jin Ho PARK ; Joon Seok CHAE
Journal of Veterinary Science 2005;6(4):327-334
We investigated the prevalence of Bartonella infections in ticks, mites and small mammals (rodents, insectivores and weasels) collected during 2001 through 2004, from various military installations and training sites in Korea, using PCR and sequence analysis of 16S rRNA, 23S rRNA and groEL heat shock protein genes. The prevalence of Bartonella spp. was 5.2% (n = 1, 305 sample pools) in ticks, 19.1% (n = 21) in mesostigmatid mites and 13.7% (n = 424 individuals) in small mammals. The prevalence within the family Ixodidae was, 4.4% (n = 1, 173) in Haemaphysalis longicornis (scrub tick), 2.7% (n = 74) in H. flava, 5.0% (n = 20) in Ixodes nipponensis, 11.1% (n = 9) in I. turdus, 33.3% (n = 3) in I. persulcatus and 42.3% (n = 26) in Ixodes spp. ticks. In rodents, the prevalence rate was, 6.7% (n = 373) in Apodemus agrarius (striped field mouse) and 11.1% (n = 9) in Eothenomys regulus (Korean red-backed vole) and in an insectivore, Crocidura lasiura, 12.1% (n = 33). Neither of the two weasels were positive for Bartonella spp. Phylogenetic analysis based on amino acid sequence of a portion of the groEL gene amplified from one A. agrarius spleen was identical to B. elizabethae species. We demonstrated the presence of Bartonella DNA in H. longicornis, H. flava and I. nipponensis ticks, indicating that these ticks should be added to the growing list of potential tick vectors and warrants further detailed investigations to disclose their possible roles in Bartonella infection cycles.
Animals
;
Bartonella/classification/*isolation&purification
;
DNA, Bacterial/isolation&purification
;
Disease Vectors
;
GroEL Protein/genetics
;
Mammals/*microbiology
;
Mites/*microbiology
;
Polymerase Chain Reaction
;
RNA, Ribosomal, 16S/genetics
;
RNA, Ribosomal, 23S/genetics
;
Ticks/*microbiology
7.No correlation between COMT genotype and entacapone benefi ts in Parkinson’s disease
Ji Seon Kim ; Ji-Young Kim ; Jong-Min Kim ; Jae Woo Kim ; Sun Ju Chung Sung ; R Kim RN ; Mi J. Kim ; Hee-Tae Kim ; Kyoung-Gyu Choi ; Dong-Ick Shin ; Young Hee Sung ; Kwang-Soo Lee ; Han-Joon Kim ; Jinwhan Cho ; Mee Young Park ; Hyun-Young Park ; SeongMin Choi ; Kun-Woo Park ; Ho-Won Lee ; Tae-Beom Ahn ; Oh Dae Kwon ; Sang-Jin Kim ; Beom S Jeon
Neurology Asia 2011;16(3):211-216
Catechol-O-methyltransferase (COMT) inhibitors are used to increase the bioavailability of therapeutic
L-dopa. We examined the effi cacy of entacapone in Parkinson’s disease patients who had daily “off”
duration of ≤2 hours, and carried different COMT polymorphisms. A total of 168 PD patients were
recruited from 19 centers. Subjects were administered with 100–200 mg of entacapone in combination
with each dose of L-dopa for 2 months. The clinical effi cacy was evaluated based on the activities
of daily living (ADL), score on the Unifi ed Parkinson’s Disease Rating Scale (UPDRS), Hoehn and
Yahr (H&Y) stage, and Clinical Global Impression (CGI). COMT polymorphisms were genotyped.
3-O-methyldopa (3-OMD) levels were measured before and after the administration of entacapone.
Entacapone administration produced signifi cant improvements in the total daily “on” duration, ADL,
UPDRS score, and H&Y stage. Nineteen patients (11.3%) had the low-activity COMT genotype,
68 patients (40.5%) had the intermediate-activity COMT genotype, and 81patients (48.2%) had the
high-activity COMT genotype. The effi cacy, and adverse effects of entacapone therapy did not differ
between the three groups. There was a signifi cant reduction in 3-OMD, but this did not differ among
the three genotypes. Entacapone provided an increased “on” duration and improved motor function
in all COMT genotypes.